Matches in Wikidata for { <http://www.wikidata.org/entity/Q83016523> ?p ?o ?g. }
Showing items 1 to 34 of
34
with 100 items per page.
- Q83016523 description "article scientifique publié en 2011" @default.
- Q83016523 description "artículu científicu espublizáu n'avientu de 2011" @default.
- Q83016523 description "scientific article published on 01 December 2011" @default.
- Q83016523 description "wetenschappelijk artikel" @default.
- Q83016523 description "наукова стаття, опублікована в грудні 2011" @default.
- Q83016523 name "Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed" @default.
- Q83016523 name "Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed" @default.
- Q83016523 type Item @default.
- Q83016523 label "Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed" @default.
- Q83016523 label "Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed" @default.
- Q83016523 prefLabel "Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed" @default.
- Q83016523 prefLabel "Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed" @default.
- Q83016523 P1433 Q83016523-977A50D0-AD23-4AB2-84B2-8C47E5E3D3D4 @default.
- Q83016523 P1476 Q83016523-B505E551-28A3-4390-AA09-4D05B41464E3 @default.
- Q83016523 P2093 Q83016523-715D6278-BCC6-42FF-BE64-B2374C48C2CC @default.
- Q83016523 P304 Q83016523-3B346A60-7EAB-4BD1-B6DE-F4649D51444B @default.
- Q83016523 P31 Q83016523-764AE5A1-E4BD-4F66-9FF7-5156CBF1618F @default.
- Q83016523 P356 Q83016523-181125D2-4A7A-4EED-A2F8-74406BF3272B @default.
- Q83016523 P478 Q83016523-987C1F35-8AFF-4CE8-946B-B016E9CBDCE5 @default.
- Q83016523 P577 Q83016523-25341CD2-7262-4BE6-8608-46D3A671C77C @default.
- Q83016523 P698 Q83016523-1543B9A1-70C0-4A7D-B712-BF82EAF62470 @default.
- Q83016523 P921 Q83016523-D9DF6A45-B29B-4D8F-91E3-1C40D1FDB72C @default.
- Q83016523 P356 MDR471 @default.
- Q83016523 P698 22180399 @default.
- Q83016523 P1433 Q326122 @default.
- Q83016523 P1476 "Follow-up with CA125 after primary therapy of advanced ovarian cancer has major implications for treatment outcome and trial performances and should not be routinely performed" @default.
- Q83016523 P2093 "G J S Rustin" @default.
- Q83016523 P304 "viii45-viii48" @default.
- Q83016523 P31 Q13442814 @default.
- Q83016523 P356 "10.1093/ANNONC/MDR471" @default.
- Q83016523 P478 "22 Suppl 8" @default.
- Q83016523 P577 "2011-12-01T00:00:00Z" @default.
- Q83016523 P698 "22180399" @default.
- Q83016523 P921 Q172341 @default.